APP and Alzheimer disease: AD may affect not only the brain, but also causes release of peripheral biomarkers, such as amyloid β (Aβ) and fractions of amyloid precursor protein (APP) in platelets [2], and an array of inflammatory factors [3], which may disclose potential pathophysiological mechanisms and provide an opportunity for early diagnosis of the disease.